对影响过敏性鼻炎患者常见过敏原的分析
Kumari Ranjana1, Maheshwari M2
1ENT Department, Madha Medical College and Hospital, Kundrathur Main Road, Kovur, Thandalam, Tamil Nadu - 600122, India.
Bioinformation
|September 18, 2023
概括
这项研究在印度奈的过敏性鼻炎 (AR) 患者中确定了常见的过敏原. 室内灰尘是最常见的过敏原,强调皮肤刺伤测试有效的AR管理.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏学 过敏学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 过敏性鼻炎 (AR) 显著影响患者的生活质量.
- 晚期炎症的症状包括打喷,鼻塞和疲劳,通常与特定的过敏原有关.
- 识别引起过敏的过敏原对于有效的过敏原避免和治疗策略至关重要.
研究的目的:
- 在被诊断患有过敏性鼻炎的患者中识别流行过敏原.
- 评估家族病史和过敏严重程度之间的相关性.
主要方法:
- 对AR的诊断是基于症状,IgE水平和绝对乙氨基酸细胞计数.
- 皮肤刺伤测试 (SPT) 用于确定过敏原的敏感性.
- 系统地记录患者和家庭病史,以及症状细节.
主要成果:
- 室内灰尘是最常见的过敏原 (92.3%),其次是花粉 (84.6%) 和Parthenium (76.9%).
- 显著比例的患者 (71.2%) 报告了过敏的家族史.
- SPT严重程度没有显示出与家族病史的统计学意义上的关联 (p=0.266).
结论:
- 这项研究成功地确定了常见的过敏原,这些过敏原在奈人口中导致过敏性鼻炎.
- 皮肤刺痛测试被强调为准确识别过敏原和指导AR治疗计划的重要工具.
关键词:
ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT ENT过敏原是一种过敏原.过敏性鼻炎 过敏性鼻炎呼吸道 呼吸道 呼吸道皮肤刺伤测试 皮肤刺伤测试更多相关视频
相关概念视频
Allergic Reactions
27.7K
Overview
27.7K
Drugs Used in Upper Respiratory Disorders: Overview
286
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
286
Drugs Used in Lower Respiratory Disorders: Overview
481
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
481
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma: Pathogenesis and Management
439
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
439
Allergic Drug Reactions
875
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
875


